Sanofi Program Aims To Provide 1M Filipino Children With Dengue Immunization
Financial Times: Sanofi to launch dengue mass vaccination program
“Sanofi will launch the world’s first mass vaccination program for dengue fever in the Philippines on Monday, bringing to fruition a 20-year development process in which the French pharmaceuticals group has invested €1.5bn [$1.7 billion]. One million Filipino schoolchildren are to be inoculated against the virus at a price of €20 [$23] a shot in a scheme that Sanofi hopes will be replicated across the swath of tropical and subtropical countries affected by the mosquito-borne disease…” (Ward, 4/4).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.